81
54
Growth Score 81 in past quarter
-9 pts
Heat Score 54 in past quarter
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
665330
MED'INN'PHARMA develops pre-clinical secretome-based drugs from human cells to cure diseases and save lives.
- Sylvain Perruche: Founder & CEO
About the Company
MED'INN'PHARMA is a biotechnology company focused on developing a new generation of drugs derived from human cells. The company is in the pre-clinical stage and specializes in secretome-based drugs, which leverage the regenerative power of human cells. Their lead drug candidates, RESOLVIX and MRT, are intravenous injectable solutions
composed of highly biocompatible human molecules in a naturally balanced composition. MED'INN'PHARMA aims to cure diseases and save lives through innovative biotechnological research and development.